Literature DB >> 19111621

Use of fractional anisotropy for determination of the cut-off value in 11C-methionine positron emission tomography for glioma.

Manabu Kinoshita1, Naoya Hashimoto, Tetsu Goto, Takufumi Yanagisawa, Yoshiko Okita, Naoki Kagawa, Haruhiko Kishima, Hisashi Tanaka, Norihiko Fujita, Eku Shimosegawa, Jun Hatazawa, Toshiki Yoshimine.   

Abstract

Multimodal imaging is one of the necessary steps in the treatment of malignant brain tumors, and use of magnetic resonance imaging (MRI) and positron emission tomography (PET) are the current gold standard technique for the morphological and biological assessment of malignant brain tumors. In addition, fractional anisotropy (FA) obtained from diffusion tensor imaging (DTI) and 11C-methionine PET are useful to determine the tumor border at the tumor and white matter interface. Although there is no question of their value, a universally accepted cut-off value to discriminate normal and abnormal tissue has not been established. In this study we attempted to calculate and determine the cut-off values in FA and 11C-methionine PET that will allow delineation of the tumor border at the tumor and white matter interface by combining these two modalities. We were able to determine individual cut-off values for 11 patients, and then found an average cut-off value in the T/N ratio of 11C-methionine PET of 1.27 and in FA of 0.26, values similar to those previously confirmed by histological study. Moreover, reconstructing images delineating the tumor border was possible combining these two imaging modalities. We propose that the combined analysis of DTI and 11C-methionine PET has the potential to improve tumor border imaging in glioma patients, providing important information for establishing neurosurgical strategies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19111621     DOI: 10.1016/j.neuroimage.2008.11.034

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  8 in total

1.  Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.

Authors:  Nobuyuki Kawai; Yukito Maeda; Nobuyuki Kudomi; Keisuke Miyake; Masaki Okada; Yuka Yamamoto; Yoshihiro Nishiyama; Takashi Tamiya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-12       Impact factor: 9.236

2.  A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.

Authors:  Makoto Ideguchi; Takafumi Nishizaki; Norio Ikeda; Tomomi Okamura; Yasue Tanaka; Natsumi Fujii; Machiko Ohno; Taichi Shimabukuro; Tokuhiro Kimura; Eiji Ikeda; Kazuyoshi Suga
Journal:  J Neurooncol       Date:  2018-03-07       Impact factor: 4.130

3.  Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates.

Authors:  David O Kamson; Csaba Juhász; Amy Buth; William J Kupsky; Geoffrey R Barger; Pulak K Chakraborty; Otto Muzik; Sandeep Mittal
Journal:  J Neurooncol       Date:  2013-01-09       Impact factor: 4.130

4.  Imaging ¹⁸F-fluorodeoxy glucose/¹¹C-methionine uptake decoupling for identification of tumor cell infiltration in peritumoral brain edema.

Authors:  Manabu Kinoshita; Tetsu Goto; Hideyuki Arita; Yoshiko Okita; Kayako Isohashi; Naoki Kagawa; Yasunori Fujimoto; Haruhiko Kishima; Eku Shimosegawa; Youichi Saitoh; Jun Hatazawa; Naoya Hashimoto; Toshiki Yoshimine
Journal:  J Neurooncol       Date:  2011-08-17       Impact factor: 4.130

5.  Quantitative volumetric analysis of gliomas with sequential MRI and ¹¹C-methionine PET assessment: patterns of integration in therapy planning.

Authors:  Javier Arbizu; S Tejada; J M Marti-Climent; R Diez-Valle; E Prieto; G Quincoces; C Vigil; M A Idoate; J L Zubieta; I Peñuelas; J A Richter
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-19       Impact factor: 9.236

6.  Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme.

Authors:  Norbert Galldiks; Roland Ullrich; Michael Schroeter; Gereon R Fink; Andreas H Jacobs; Lutz W Kracht
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

7.  Diffusion tensor-based tumor infiltration index cannot discriminate vasogenic edema from tumor-infiltrated edema.

Authors:  Manabu Kinoshita; Tetsu Goto; Yoshiko Okita; Naoki Kagawa; Haruhiko Kishima; Naoya Hashimoto; Toshiki Yoshimine
Journal:  J Neurooncol       Date:  2009-08-21       Impact factor: 4.130

8.  Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy.

Authors:  Kazuhiro Miwa; Masayuki Matsuo; Shin-ichi Ogawa; Jun Shinoda; Kazutoshi Yokoyama; Jitsuhiro Yamada; Hirohito Yano; Toru Iwama
Journal:  Radiat Oncol       Date:  2014-08-14       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.